Response to: 'TARA Study: a new perspective on tapering drugs in RA' by Mishra et al

Ann Rheum Dis. 2020 Jul;79(7):e80. doi: 10.1136/annrheumdis-2019-215641. Epub 2019 May 20.

Authors

Elise van Mulligen¹, Johanna M W Hazes², Angelique E A M Weel^{2

3}, Pascal H P de Jong²

Affiliations

¹ Department of Rheumatology, Erasmus MC, Rotterdam, The Netherlands elise.vanmulligen@erasmusmc.nl.
² Department of Rheumatology, Erasmus MC, Rotterdam, The Netherlands.
³ Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands.

No abstract available

Keywords: DMARDs (biologic); DMARDs (synthetic); methotrexate; rheumatoid arthritis; treatment.

Publication types

Comment

MeSH terms

Antirheumatic Agents*
Arthritis, Rheumatoid*
Humans
Tumor Necrosis Factor Inhibitors

Substances

Antirheumatic Agents
Tumor Necrosis Factor Inhibitors